AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 17 filers reported holding AZURRX BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARSONS CAPITAL MANAGEMENT INC/RI | 434,783 | $1,117,000 | 0.12% |
| J. Goldman & Co LP | 425,358 | $1,093,000 | 0.08% |
| 683 Capital Management, LLC | 400,000 | $1,028,000 | 0.07% |
| ARDSLEY ADVISORY PARTNERS LP | 150,000 | $386,000 | 0.05% |
| GILDER GAGNON HOWE & CO LLC | 556,537 | $1,430,000 | 0.02% |
| TIEDEMANN ADVISORS, LLC | 60,000 | $154,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 131,456 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,780 | $59,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $1,285,000 | 0.00% |
| Rockefeller Capital Management L.P. | 16,971 | $44,000 | 0.00% |